コンテンツへスキップ
ヒト伏在静脈内皮細胞(HSVEC)
ティッシュ
Saphenous vein
病気
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
転移部位
Not applicable (normal, non-tumorigenic primary cell)
同義語
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

ヒト伏在静脈内皮細胞(HSVEC)

Primary cell · 製品番号 300699

Venous endothelium for bypass graft research

€1,220.00税・送料別

カスタマイズ/おすすめ

受注生産
1

01概要

説明

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

ティッシュ
Saphenous vein
病気
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
転移部位
Not applicable (normal, non-tumorigenic primary cell)
用途
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
同義語
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02寄付者

ドナーの年齢
Lot-specific (see CoA)
民族
Lot-specific (see CoA)

03分類

生物
人間
セックス
ロット別
成長特性
アドヘレント
GMOの有無
非遺伝子組み換え
GMOのステータスに関する詳細
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
バイオセーフティレベル
1

04特徴

形態学
Cobblestone (endothelial)
細胞の種類
Primary endothelial cells
腫瘍形成性
No
倍増時間
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05取り扱いと飼育

培地
Endothelial Cell Growth Medium
培養雰囲気

37°C, 5% CO2, saturated humidity.

サプリメント
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
解離試薬
Subculture reagents as recommended on the certificate of analysis
フラスコのコーティング
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
継代培養

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

分割比率
1 to 3
播種密度
More than 6,000 cells/cm²
流体の更新
24 hours after seeding, then every 48 to 72 hours
解凍後の回復

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

解凍と培養
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06品質管理と凍結保存

無菌性

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

凍結培地
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
保管条件

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

配送条件

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07発現と感受性

表面抗原
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
発現している受容体
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08識別子

引用
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI 納税者番号
9606
セロサウルス
Not assigned